Drug-Coated Balloons for Complex Femoropopliteal Lesions 2-Year Results of a Real-World Registry

JACC: Cardiovascular Interventions

Volumn 9, Issue 7, 2016, Pages 715-724

  Schmidt, Andrej ^a   Piorkowski, Michael ^b   Görner, Henrik ^a   Steiner, Sabine ^a   Bausback, Yvonne ^a   Scheinert, Susanne ^a   Banning Eichenseer, Ursula ^a   Staab, Holger ^a   Branzan, Daniela ^a   Varcoe, Ramon L ^c   Scheinert, Dierk ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b Cardioangiological Center Bethanien   (Germany)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

drug coated balloon; femoral artery; long lesion; popliteal artery; restenosis

Indexed keywords

AGED; ANATOMIC LANDMARK; ANGIOGRAPHY; ANKLE BRACHIAL INDEX; ARTERIOVENOUS FISTULA; ARTERY EMBOLISM; ARTICLE; ATHERECTOMY DEVICE; ATHEROSCLEROSIS; BLEEDING; BLOOD VESSEL CALCIFICATION; BLOOD VESSEL CATHETERIZATION; BLOOD VESSEL PARAMETERS; CAUSE OF DEATH; CHRONIC DISEASE; CLAUDICATION; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; DEVICE SAFETY; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; DRUG COATED BALLOON; DRUG ELUTING STENT; EXCIMER LASER; FALSE ANEURYSM; FEMALE; FEMOROPOPLITEAL ATHEROSCLEROSIS; FEMOROPOPLITEAL IN STENT RESTENOSIS; FEMOROPOPLITEAL RESTENOSIS; FOLLOW UP; GENERAL CONDITION DETERIORATION; HEART DISEASE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IN-STENT RESTENOSIS; LEG AMPUTATION; LEG REVASCULARIZATION; MAJOR CLINICAL STUDY; MALE; MESENTERIC ISCHEMIA; MORTALITY RATE; MULTIPLE ORGAN FAILURE; OBESITY; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BALLOON; PERFORATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RESTENOSIS; RETROSPECTIVE STUDY; RISK REDUCTION; SEPTIC SHOCK; SEX DIFFERENCE; SMOKING; STENT THROMBOSIS; SURVIVAL RATE; THROMBECTOMY; THROMBECTOMY DEVICE; TREATMENT RESPONSE; VASCULAR PATENCY; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; DEVICES; DIAGNOSTIC IMAGING; DRUG EFFECTS; EQUIPMENT DESIGN; FEMORAL ARTERY; KAPLAN MEIER METHOD; MIDDLE AGED; ODDS RATIO; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; RECURRENT DISEASE; REGISTER; RISK FACTOR; STATISTICAL MODEL; STENT; TIME FACTOR; TREATMENT OUTCOME; VASCULAR ACCESS DEVICE;

BIOCOMPATIBLE COATED MATERIAL; CARDIOVASCULAR AGENT;

AGED; ANGIOPLASTY, BALLOON; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; COATED MATERIALS, BIOCOMPATIBLE; EQUIPMENT DESIGN; FEMALE; FEMORAL ARTERY; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES; VASCULAR PATENCY;

EID: 84962385406     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2015.12.267     Document Type: Article

References (26)

1. D. Scheinert, J.R. Laird, M. Schröder, H. Steinkamp, J.O. Balzer, and G. Biamino Excimer laser-assisted recanalization of long, chronic superficial femoral artery occlusions J Endovasc Ther 8 2001 156 166
2. E.J. Armstrong, H. Saeed, B. Alvandi, and et al. Nitinol self-expanding stents vs. balloon-angioplasty for very long femoropopliteal lesions J Endovasc Ther 21 2014 34 43
3. M. Bosiers, K. Deloose, J. Callaert, and et al. Results of the Protege EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions J Vasc Surg 54 2011 1042 1050
4. J. Lammer, T. Zeller, K.A. Hausegger, and et al. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions J Am Coll Cardiol 62 2013 1320 1327
5. D. Scheinert, S. Scheinert, J. Sax, and et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting J Am Coll Cardiol 45 2005 312 315
6. D. Scheinert, S. Duda, T. Zeller, and et al. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty J Am Coll Cardiol Intv 7 2014 10 19
7. G. Tepe, J. Laird, P. Schneider, and et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial Circulation 131 2015 495 502
8. M. Werk, T. Albrecht, D.-R. Meyer, and et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty. Evidence from the randomized PACIFIER trial Circ Cardiovasc Interv 5 2012 831 840
9. K. Rosenfield, M.R. Jaff, C.J. White, and et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease N Engl J Med 373 2015 145 153
10. A. Micari, A. Cioppa, G. Vadala, and et al. 2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry J Am Coll Cardiol Intv 6 2013 282 289
11. H. Schroeder, D.-R. Meyer, B. Lux, and et al. Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: outcomes from the ILLUMINATE first-in-human study Catheter Cardiovasc Interv 86 2015 278 286
12. T. Zeller, A. Rastan, R. Macharzina, and et al. Drug-coated balloons vs. drug-eluting stents for treatment of femoropopliteal lesions J Endovasc Ther 21 2014 359 368
13. G. Tepe, B. Schnorr, T. Albrecht, and et al. Angioplasty of femoro-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial J Am Coll Cardiol Intv 8 2015 109 110
14. P. Dick, S. Sabeti, W. Mlekusch, and et al. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience Radiology 248 2008 297 302
15. A. Tosaka, Y. Soga, O. Iida, and et al. Classification and clinical impact of restenosis after femoropopliteal stenting J Am Coll Cardiol 59 2012 16 23
16. E.J. Armstrong, S. Singh, G.D. Singh, and et al. Angiographic characteristics of femoropopliteal in-stent restenosis: association with long-term outcomes after endovascular intervention Catheter Cardiovasc Interv 82 2013 1168 1174
17. E. Stabile, V. Virga, L. Salemme, and et al. Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis J Am Coll Cardiol 60 2012 1739 1742
18. V. Virga, E. Stabile, G. Biamino, and et al. Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up J Am Coll Cardiol Intv 7 2014 411 415
19. T. Zeller, M.D. Dake, G. Tepe, and et al. Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents J Am Coll Cardiol Intv 6 2013 274 281
20. M. Bosiers, K. Deloose, J. Callaert, and et al. Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial J Endovasc Ther 22 2015 1 10
21. M. Schillinger, M. Exner, W. Mlekusch, and et al. Effect of smoking on restenosis during the 1st year after lower-limb endovascular interventions Radiology 231 2004 831 838
22. Z.J. Wang, F. Gao, W.J. Cheng, Q. Yang, and Y.J. Zhou Body mass index and repeat revascularization after percutaneous coronary intervention: a meta-analysis Can J Cardiol 31 2015 800 808
23. F. Fanelli, A. Cannavale, M. Gazzetti, and et al. Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease Cardiovasc Intervent Radiol 37 2014 898 907
24. M. Werner, A. Paetzold, U. Banning-Eichenseher, and et al. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registry EuroIntervention 10 2014 861 868
25. M. Bosiers, P. Peeters, J. Tessarek, and et al. The Zilver PTX single arm study: 12-month results from the TASC C/D lesion subgroup J Cardiovasc Surg 54 2013 115 122
26. S.D. Thomas, R.R.A. McDonald, and R.L. Varcoe Vasculitis resulting from a superficial femoral artery angioplasty with a paclitaxel-eluting balloon J Vasc Surg 59 2014 520 523